LIPOSORBER
Device
Kaneka Pharma America LLC
Total Payments
$616,797
Transactions
91
Doctors
39
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2021 | $456,485 | 62 | 21 |
| 2020 | $160,312 | 29 | 29 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $289,148 | 40 | 46.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $172,614 | 33 | 28.0% |
| Unspecified | $153,535 | 17 | 24.9% |
| Education | $1,500 | 1 | 0.2% |
Payments by Type
General
$463,262
74 transactions
Research
$153,535
17 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Treatment of Drug-resistant Adult and Pediatric Primary Focal Segmental Glomerulousclerosis Using the Liposorber LA-15 System | Kaneka Pharma America LLC | $68,740 | 0 |
| Defining the Inflammmatory Monocyte and Cytokine Changes Associated with Primary Investigator Calvine Yeang | Kaneka Pharma America LLC | $43,333 | 0 |
| Treatment of Drug-resistant Adult and Primary Focal Segmental Glomerulousclerosis Using the Liposorber LA-15 System | Kaneka Pharma America LLC | $15,413 | 1 |
| Treatment of Drug-resistant Pediatric Primary Focal Segmental Glomerulousclerosis Using the Liposorber LA-15 System | Kaneka Pharma America LLC | $3,000 | 0 |
Top Doctors Receiving Payments for LIPOSORBER — Page 2
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Public Health & General Preventive Medicine | Sebastopol, CA | $1,607 | 2 |
| , M.D | Cardiovascular Disease | New York, NY | $1,500 | 1 |
| , MD | Endocrinology, Diabetes & Metabolism | Portland, OR | $1,500 | 1 |
| , C.R.N.P | Nurse Practitioner | Baltimore, MD | $1,500 | 1 |
| , M.D | Cardiovascular Disease | Rochester, MN | $1,500 | 1 |
| , M.D., PH.D | Internal Medicine | Mobile, AL | $1,258 | 1 |
| Savitha Subramanian | Internal Medicine | Seattle, WA | $1,235 | 1 |
| , M.D | Nuclear Cardiology | Oklahoma City, OK | $1,226 | 2 |
| , M.D | Internal Medicine | Burlington, MA | $864.50 | 1 |
| , M.D | Pediatrics | Seattle, WA | $589.00 | 1 |
| , MD PHD | Blood Banking & Transfusion Medicine | Maywood, IL | $446.50 | 1 |
| , MD | Anatomic Pathology & Clinical Pathology | Chapel Hill, NC | $408.00 | 1 |
| , M.D | Nephrology | New York, NY | $237.50 | 1 |
| , M.D | Cardiovascular Disease | Reading, PA | $151.05 | 1 |
| , M.D | Pediatric Nephrology | Chicago, IL | $65.50 | 1 |
Ad
Manufacturing Companies
- Kaneka Pharma America LLC $616,797
Product Information
- Type Device
- Total Payments $616,797
- Total Doctors 39
- Transactions 91
About LIPOSORBER
LIPOSORBER is a device associated with $616,797 in payments to 39 healthcare providers, recorded across 91 transactions in the CMS Open Payments database. The primary manufacturer is Kaneka Pharma America LLC.
Payment data is available from 2020 to 2021. In 2021, $456,485 was paid across 62 transactions to 21 doctors.
The most common payment nature for LIPOSORBER is "Consulting Fee" ($289,148, 46.9% of total).
LIPOSORBER is associated with 4 research studies, including "Treatment of Drug-resistant Adult and Pediatric Primary Focal Segmental Glomerulousclerosis Using the Liposorber LA-15 System" ($68,740).